(Sharecast News) - Science and technology investor IP Group said portfolio company Microbiotica has closed a £36m financing in which it invested £4m.
Microbiotica, a clinical-stage biopharma company developing a pipeline of orally-dosed, precision microbiome medicines, said the cash will support advancement of its potential treatment for ulcerative colitis into a...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE